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In recent years, remarkable versatility of polyketide synthases (PKSs) has been recognized; both in terms of their
structural and functional organization as well as their ability to produce compounds other than typical secondary
metabolites. Multifunctional Type I PKSs catalyze the biosynthesis of polyketide products by either using the same
active sites repetitively (iterative) or by using these catalytic domains only once (modular) during the entire
biosynthetic process. The largest open reading frame in Mycobacterium tuberculosis, pks12, was recently proposed to
be involved in the biosynthesis of mannosyl-b-1-phosphomycoketide (MPM). The PKS12 protein contains two complete
sets of modules and has been suggested to synthesize mycoketide by five alternating condensations of methylmalonyl
and malonyl units by using an iterative mode of catalysis. The bimodular iterative catalysis would require transfer of
intermediate chains from acyl carrier protein domain of module 2 to ketosynthase domain of module 1. Such
bimodular iterations during PKS biosynthesis have not been characterized and appear unlikely based on recent
understanding of the three-dimensional organization of these proteins. Moreover, all known examples of iterative
PKSs so far characterized involve unimodular iterations. Based on cell-free reconstitution of PKS12 enzymatic
machinery, in this study, we provide the first evidence for a novel ‘‘modularly iterative’’ mechanism of biosynthesis. By
combination of biochemical, computational, mutagenic, analytical ultracentrifugation and atomic force microscopy
studies, we propose that PKS12 protein is organized as a large supramolecular assembly mediated through specific
interactions between the C- and N-terminus linkers. PKS12 protein thus forms a modular assembly to perform
repetitive condensations analogous to iterative proteins. This novel intermolecular iterative biosynthetic mechanism
provides new perspective to our understanding of polyketide biosynthetic machinery and also suggests new ways to
engineer polyketide metabolites. The characterization of novel molecular mechanisms involved in biosynthesis of
mycobacterial virulent lipids has opened new avenues for drug discovery.
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Introduction
Polyketide synthases (PKSs) are multifunctional enzymes
that assemble simple CoA-thioesters to form complex
metabolites. These proteins are classified as Type I, Type II,
and Type III based on their protein architecture. Type I PKSs
contain various catalytic domains on a single polypeptide
chain, which are functionally grouped to form a module.
These are further classified as modular and iterative. In
modular type I PKSs, each set of catalytic domains is used
once during the entire cycle of biosynthesis, whereas iterative
PKSs repeatedly use these functional domains [1–5]. Type II
PKSs, on the other hand, assemble different catalytic domains
to form a noncovalent multienzyme complex [6,7]. Both these
types of PKSs require a carrier domain on which intermedi-
ates are tethered as acyl-thioesters. Type III PKSs are quite
different and are classified along with other PKSs due to their
mechanistic similarity in the process of 2-carbon condensa-
tions [8,9]. Type I and II PKSs utilize three core catalytic
domains, ketosynthase (KS), acyl transferase (AT), and acyl
carrier protein (ACP), to carry out decarboxylative conden-
sations. The b-keto intermediates are processed by auxiliary
domains; ketoreductase (KR), dehydratase (DH), and enoyl
reductase (ER), that dictate the overall chemistry of the
metabolite.
Research in recent years has provided new themes that
enhance the ability of PKSs to produce a wide array of
metabolites that could mediate processes of significant
functional importance. For example, AT-less Type I PKSs
have been characterized, which utilize a discrete AT domain
to load extender units in trans [10]. Fungal Type I iterative
PKSs suggest new mechanistic basis of selective utilization of
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auxiliary reductase and methyl transferase domains [11–13].
The catalytic and mechanistic versatility of mycobacterial
PKSs in generating complex virulent lipids have also been
recently recognized [3,14]. A family of fatty-acyl AMP ligases
has been demonstrated to facilitate biochemical crosstalk
between fatty acid synthases (FASs) and PKSs [15]. An
emerging family of type III PKSs involved in biosynthesis of
novel resorcinolic lipids has also been characterized from
Azotobacter vinelandii and Neurospora crassa [16,17]. Since
metabolic diversity far exceeds our present understanding
of the biosynthetic capability of this family of proteins, it is
tempting to speculate that many new mechanistic and
organizational features of PKSs remain to be decoded.
In this study, we report a novel mechanism of iterative
catalysis for a bimodular multifunctional PKS12 (Rv2048c)
protein from M. tuberculosis. This protein is involved in
biosynthesis of a phosphoglycolipid called mannosyl-b-1-
phosphomycoketide (MPM) [18]. The chemical structure of
mycoketide lipid chain has been proposed to originate from
repetitive condensations of methylmalonate and malonate
units with medium-chain fatty acyl starters. Involvement of
PKS12 protein in the biosynthesis of MPMs has been
previously supported by genetic studies. By using a combi-
nation of biochemical, computational, mutagenic, analytical
ultracentrifugation, and atomic force microscopy (AFM)
studies, we propose that PKS12 protein is organized in a
large supramolecular assembly mediated through specific
interactions between the N- and C-terminus linkers (Nter and
Cter, respectively). This assembly of PKS12 protein provides
evidence for the intermolecular iterative mechanism for
mycoketide biosynthesis. Our studies thus provide the first
evidence for a novel ‘‘modularly iterative’’ mechanism for
biosynthesis by PKSs.
Results
Correspondence between Mycoketide Structure and
PKS12 Catalytic Domains
The lipid portion of MPM, also referred to as mycoketide,
consists of saturated alkyl chain with methyl branching at
every fourth carbon (Figure 1). The total number of carbons
could vary from C30 to C34 in different mycobacterial species
[18]. Due to its similarity with mannosyl-b-1-phosphodolichol
(MPD), initial structural characterization had suggested an
isoprenoid mode of biosynthesis [19]. Based on genetic
studies, PKS12 protein was recently shown to be involved in
the biosynthesis of mycoketide. It is proposed that the
biosynthesis would involve an iterative mode of catalysis. In
mycobacteria, PKS12 is the largest protein, comprising 12
catalytic domains constituting two modules (Figure 1). Both
these modules contain a complete set of catalytic and
auxiliary domains that could add 2-carbon ketide units and
also simultaneously carry out a three-step reduction to a
saturated alkyl chain. Since mycoketide chemical structure
contains branching at every alternate ketide unit, a possible
iterative mechanism would involve alternate use of two
modules wherein one module would condense a branched
C3 ketide unit and the next would add a C2 unit. This would
indicate that the two modules of PKS12 would be specific for
methylmalonate and malonate extender units, respectively.
The AT domains of PKSs characteristically show strict
substrate specificity; however, there are examples in which
the same AT domain could utilize both malonate and
methylmalonate units [20]. Such promiscuity of AT domains
in PKS12 could result in a complex mechanism of biosyn-
thesis. We therefore decided first to dissect the specificity
dictated by the two AT domains of PKS12 protein.
Heterologous Expression of 431-kDa PKS12 Protein and
Characterization of AT Domain Specificities
The 12,456-bp pks12 gene was cloned in T7 expression
vector such that the protein would be expressed with a C-
terminal His-tag. The N- and C- terminal ends were suitably
engineered, and the central region of pks12 was spliced from
overlapping shotgun library of mycobacterial D8 BAC clone.
The phosphopantetheinylation of the ACP domain of PKS12
was achieved by coexpression of pRSG56 (a surfactin
phosphopantetheinyl transferase [Sfp] expression plasmid)
in BL21-DE3 strain of Escherichia coli [21,22]. Purification by
Ni2þ-NTA affinity chromatography followed by anion ex-
change chromatography showed a protein band running
above the 212-kDa marker on the SDS-PAGE (Figure 2B,
lane1). Since E. coli protein biosynthetic machinery is not
programmed to synthesize such large proteins, and it is not
easy to estimate exact molecular weight from SDS-PAGE for
such large proteins, we performed peptide mapping by using
mass spectrometry. Our analysis showed good coverage over
the entire length of the protein, confirming expression of
complete PKS12 protein. The specificity of AT domains was
probed by using 14C malonyl coenzyme A (MCoA) and 14C
methylmalonyl coenzyme A (MMCoA). SDS-PAGE gel-bind-
ing assays clearly showed that PKS12 could be radiolabeled
with both of these substrates (Figure 2B, lanes 2 and 3).
However, the specificity of individual AT domains to load
extender units could not be determined. We therefore
decided to engineer a single-module construct of PKS12.
Engineered Single-Module PKS12 Protein and Assignment
of AT Domain Specificity
Based on previous understanding of engineering single-
module PKS proteins, we utilized the in-frame BsaBI
restriction sites present in the pks12 gene to delete module
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Author Summary
Polyketide synthases (PKSs) form a large family of multifunctional
proteins involved in the biosynthesis of diverse classes of natural
products. Mycobacterium tuberculosis (Mtb) exploits these polyke-
tide biosynthetic enzymes to synthesize complex lipids, many of
which are essential for its virulence. PKSs utilize two common
mechanistic themes to produce these metabolites: (1) modular—in
which each set of catalytic sites is used only once during the entire
biosynthetic process and (2) iterative—in which the same set of
active sites is used repeatedly. Our study with PKS12 protein from
Mtb (the largest protein in this genome) reveals a third mechanism
for polyketide biosynthesis. In this hybrid ‘‘modularly iterative’’
mechanism, PKS12 protein forms a supramolecular assembly to
perform repetitive cycles of iterations. The protein assembly is
formed by specific intermolecular interactions between N- and C-
terminus linkers, analogous to modular PKSs. Our study adds a new
dimension to the existing catalytic and mechanistic versatility of
PKSs, providing a new perspective on how metabolic diversity could
be generated by different combinations of existing functional
scaffolds.
1. This engineered PKS12D1 protein retained both the Nter
and Cter and all the catalytic domains of module 2 (Figure
2A). PKS12D1 protein was expressed and purified analogous
to PKS12 (Figure 2C, lane 2). The specificity of AT domain
was again investigated by using radiolabeled substrates.
PKS12D1 protein specifically utilized MCoA and no labeling
of protein could be identified with MMCoA (Figure 2C, lanes
3 and 4). The specificity of this labeling was further confirmed
by making a point mutation of the catalytic Ser amino acid
residue of the AT domain. The S2672A null mutant protein,
PKS12D1-AT8, was now incapable of loading any of these two
extender units (Figure 2C, lanes 5 and 6). These studies clearly
demonstrate specificity of module 2 for malonate unit and
suggest that the module 1 of PKS12 protein would add a
methylmalonate unit.
In order to unambiguously determine the specificity of
AT1, we constructed an AT2 null mutant of PKS12, PKS12-
AT28 (Figure 2A). This mutant protein could be specifically
radiolabeled with 14C MMCoA and not with 14C MCoA
(Figure 2B, lanes 4 and 5) thus demonstrating specificity of
module 1 for MMCoA. These studies clearly demonstrate that
the biosynthesis of mycoketide would involve alternate use of
module 1 and module 2, respectively. The final assembly
would involve five such cycles of iterations, and in terms of
thiotemplate-based enzymology, would require transfer of
growing polyketide chain from the ACP domain of module 2
to the KS domain of module 1. Such bimodular iterations
during PKS biosynthesis have not been demonstrated. We
therefore decided to investigate whether PKS12 protein by
itself would be competent to produce mycoketide chain.
Cell-Free Reconstitution of PKS12 and PKS12D1 Protein
The catalytic activity of PKS12 protein was analyzed by
incubating various starters (C6–C18) acyl-N-acetyl cysteamines
(NACs) with radiolabeled extender units MCoA, MMCoA, and
NADPH. Since PKS12 protein does not contain a chain-
releasing domain, the enzyme-bound products were released
by alkali hydrolysis. The extracted products were analyzed by
performing radio-thin layer chromatography (TLC) experi-
ments. Autoradiography analysis showed a diffused band at
an Rf of about 0.5 (Figure3A). When either of the extender
units was omitted from the assays, such broad bands were not
observed (Figure S1). PKS12 protein showed preference for
small-/medium-chain starter fatty acyl substrates. Radioactive
bands observed at lower Rf were degradative products of acyl-
CoAs and varied from assay to assay. Enzymatic assays of
PKS12 protein with 9-hydroxy decanoyl NAC-thioester
shifted Rf of the final product to about 0.2 (Figure3A, lane
8). Hydroxyl modification at x-position of fatty acids
dramatically alters the Rf value of products owing to the
polar nature of starter unit and is an interesting approach to
confirm enzymatic activity. Furthermore, incubation of
PKS12 protein with KS inhibitor cerulenin showed no
radioactive bands (Figure S2). We speculated that the diffused
radioactive band could correspond to different intermediates
formed during various stages of iterations. Our previous
studies with another single module iterative enzyme, myco-
cerosic acid synthase, had shown presence of similar diffused
bands [20]. The apparent catalytic turnover (kcat/KM) of the
final product was estimated to be 42.4 lM1 sec1 (Figure 3B).
This reconstitution provided confidence that PKS12 protein
could indeed synthesize mycoketide metabolite. For exper-
imental ease, detailed characterization of products was
performed with PKS12D1 protein.
In order to biochemically reconstitute the PKS12D1
protein, we coincubated the protein with different acyl-
NAC starters (C6–C18) along with NADPH and radiolabeled
MCoA. Alkaline hydrolysis followed by radio-TLC analysis
revealed substrate specificity for short-/medium-chain start-
ers (Figure3C). PKS12D1 showed robust activity with the
Figure 1. Involvement of PKS12 Protein in the Biosynthesis of Mannosyl-b-1-Phosphomycoketide
A schematic representation of bimodular PKS12 protein from M. tuberculosis, which is required for the biosynthesis of mycoketide. The two modules of
PKS12 are colored in blue (AT specificity for methylmalonyl CoA) and buff (AT specificity for malonyl CoA), and the N- and Cters are indicated in green
and red, respectively. Individual domains are drawn as small boxes in the two modules. Mycoketide chain originates from repetitive condensations of
methylmalonate and malonate units with medium-chain fatty acyl starters. This saturated chain is released from PKS12 by an unknown mechanism,
which is followed by reduction, phosphorylation, and mannosylation to form MPM.
doi:10.1371/journal.pbio.0060163.g001
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apparent kcat/KM of 104.22 lM
1 sec1 (Figure 3D). The
activity was confirmed by constructing active site KS and AT
null mutants, C2226A and the S2672A. Both these proteins
were purified to homogeneity and were found to be catalyti-
cally inactive (Figure S3), thus confirming in vitro recon-
stitution of the PKS12D1 protein. A 2.5-fold improved
catalytic activity of PKS12D1 along with better protein
expression provided a good system to delineate the mecha-
nisms involved in mycoketide formation.
In order to unequivocally characterize the PKS12D1
product, we designed a radio high performance liquid
chromatography (HPLC)-based assay, wherein fatty acids
with different carbon chain lengths (C3 to C18) were separated
on a reverse-phase column by using a ternary solvent system.
Products formed from the PKS12D1 reactions primed with
hexanoyl-NAC starter unit were first analyzed on TLC plates.
The diffused product band was eluted and further subjected
to HPLC analysis. Six radioactive products could be detected
in the standard assay (Figure 4A). PKS12D1 protein is
expected to add two carbon units during each cycle of chain
extension. As can be observed from Figure 4A, three of these
products showed identical retention times with standard
radioactive fatty acids (C12, C16, and C18) (standard spectra
shifted to the left for clarity). Other radioactive peaks, based
on retention times and on our understanding of the
programming of PKS enzymology, would correspond to C8,
C10, and C14, respectively. Radio-TLC analysis of these HPLC-
purified products showed a systematic change in Rf (Figure
4B), which could be unambiguously confirmed with their
standard fatty acids. Mass spectrometric analysis of these
peaks further confirmed the identity of products. Particularly
in the case of longer chain products, the isotopic 14C peak was
enhanced as compared to the corresponding 13C peak (Figure
4C). The electrospray tandem mass spectrometry (ESI-MS/MS)
pattern for 12C and 14C peaks showed expected dehydration
and decarboxylation peaks (Figure 4D and 4E). Based on these
studies, we propose that the single-module construct of
PKS12 protein can perform up to six rounds of chain
extension in our in vitro enzymatic assays.
Structural Analysis of PKS12 and N- and C-Terminus
Linkers
Our in vitro characterizations of PKS12 protein validates
that this bimodular protein could indeed synthesize mycoke-
tide product. An intriguing feature of the PKS12 catalysis
would be the long-range transfer of ketide chain from
module 2 to module 1. The recent structures of FAS [23]
and KS-AT didomain from erythromycin PKS [24] provide an
opportunity to investigate this possibility in the three-
dimensional space. PKSs are proposed to be X-shaped
homodimeric proteins, in which KS, DH, and ER provide
the majority of the interfacial contacts in a given module.
Modules that are present on two separate polypeptide chains
interact through small helices. These helices protrude out
from the N- and C-terminus ends to form an end-to-end
organization [2,25,26]. The mammalian FAS structure also
indicates similar end-to-end packing for consecutive modules
in two neighboring unit cells along the common two-fold axis
Figure 2. Determination of Specificities of the AT Domains and Construction of Single-Module PKS12D1 Protein
(A) The PKS12D1 protein was constructed by deleting module 1 from the clone encoding PKS12 protein. The DNA encoding KS domains from module 1
and module 2 contains a conserved BsaBI restriction endonuclease site, which facilitated module 1 deletion. PKS12D1 retains N- and Cters of PKS12
protein. PKS12 AT2 null mutant (PKS12AT28) and PKS12D1 AT null mutant (PKS12DAT8), both mutated at the catalytic Ser residue were constructed by
using standard SDM protocols. The mutations in the domains are marked in red.
(B) Labeling of PKS12 protein with radioactive extender units. Lane 1 shows the Coomassie-stained, purified PKS12 protein (431 kDa). The protein could
be labeled with both 14C-MCoA (lane 2) and 14C-MMCoA (lane 3). AT2 (S2672A) point mutant of PKS12 is labeled by 14C-MMCoA (lane 5) and not by 14C-
MCoA (lane 4) depicting specificity of module 1 for MMCoA and module 2 for MCoA.
(C) Labeling of PKS12D1 protein with radioactive extender units. Lanes 1 and 2 show the Coomassie-stained, purified PKS12 (431 kDa) and PKS12D1
protein (234 kDa). PKS12D1 protein could be radiolabeled with 14C-MCoA (lane 3) but not with14C-MMCoA (lane 4). AT (S2672A) mutant protein of
PKS12D1 does not incorporate any radioactive label (lanes 5 and 6).
doi:10.1371/journal.pbio.0060163.g002
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of the dimer [23]. This organization is likely to be conserved
for modules, which are present on a single polypeptide chain
[2]. Figure 5A shows the model of PKS12 generated by
docking two KS-AT-DH-ER-KR-ACP modules in an end-to-
end orientation. The template for KS-AT-DH-ER-KR has
been taken from mammalian FAS structure, whereas the
relative orientation of ACP with respect to KS has been fixed
based on the ACP-KS interactions as seen in the yeast FAS
structure [27]. Based on our model, the distances between the
catalytic centers of ACP2 and KS1 are in the range of 130 A˚
(Figure 5B). Despite the inherent flexibility of the ACP
domain, chain transfer over such a large distance seems
unfeasible. This then raises a paradoxical problem for the
iterative biosynthesis of mycoketide by PKS12.
Type I multifunctional PKSs synthesize polyketide prod-
ucts by either using an iterative mechanism with repetitive
utilization of catalytic domains or by an assembly-line
modular catalysis involving single use of active sites [28].
However, the programming that dictates these two mecha-
nisms of biosynthesis has not been elucidated. Systematic
analysis of various domains and linkers suggests an interest-
ing comparison. The Cter modular proteins varies between
70–110 amino acids, whereas iterative linkers are typically
smaller than 25 amino acids (G. Yadav and D. Mohanty;
unpublished data). Moreover, a strong propensity to form
helices could be observed in the case of modular linkers. A
close examination of PKS12 protein suggested similarity to
modular proteins, where the Cter is of 81 amino acids and
also shows structural propensity to form three helices. This is
in contrast to the Cters of two other mycobacterial iterative
proteins, mycocerosic acid synthase (MAS) and PKS2 that
have Cters of 11 residues and 13 residues, respectively, with
no significant structural propensities. Furthermore, the
analysis of the Nter of PKS12 also showed propensity to
form a coiled-coil motif. Based on structural understanding
of PKS proteins, the N- and C-termini cannot fold back to
interact with one another. We therefore speculate that PKS12
protein molecules may form large supramolecular assemblies
that interact with each other through the N- and C-terminus
helices. We performed detailed analysis of PKS12 linkers to
identify crucial residues involved in this docking complex. A
chimeric model based on SCRWL [29] was built that utilizes
the nuclear magnetic resonance (NMR) template of 6-
deoxyerythronolide B synthase (DEBS) [25]. The residues in
the helices of DEBS have been replaced by corresponding
amino acids of PKS12, but the loops are retained (Figure 5C).
The model was energy minimized using CVFF force field of
Insight II [30]. Any two residues less than 5 A˚ apart were
considered as interacting. This analysis led us to identify two
key ionic interactions between C- and Nters (D4137 with H7
and R4147 with E20).
Analytical Ultracentrifugation and Mutagenic Analysis of
Interacting Linker Amino Acid Residues
In order to explore macromolecular organization of
PKS12, we resorted to sedimentation velocity studies using
Figure 3. Biochemical Characterization of PKS12 and PKS12D1 Proteins
(A)Radio-TLC characterization of PKS12 products. Lane 1 to 8 show the propionyl, hexanoyl, octanoyl, decanoyl, lauroyl, palmitoyl, stearoyl, and 9-
hydroxy decanoyl N-acetyl cysteamine thioester primed products. No product is formed in the absence of protein (lane 9).
(B) Time course of product formation catalyzed by PKS12 protein. The error bars correspond to three independent experiments, and the data points are
an average of all three.
(C) Radio-TLC characterization of PKS12D1 products. Lane 1 to 8 show the propionyl, hexanoyl, octanoyl, decanoyl, lauroyl, palmitoyl, stearoyl, and 9-
hydroxy decanoyl N-acetyl cysteamine thioester primed products. No product is formed in the absence of protein (lane 9).
(D) Time course of product formation catalyzed by PKS12D1 protein. The error bars correspond to three independent experiments, and the data points
are an average of all three.
doi:10.1371/journal.pbio.0060163.g003
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the analytical ultracentrifuge. This analysis provides a
sensitive measure to ascertain whether the sample consists
of single or multiple species [31]. At low salt concentrations,
both PKS12 and PKS12D1 showed a spread in the sediment-
ing boundaries (Figure 6A and 6B). These data could not be
fitted to determine a unique sedimentation coefficient and
suggested a possibility of multiple stable aggregation states.
At the same time, we also performed control experiments
with other mycobacterial PKS proteins. Both PKS13 and
PKS2, which are single-module proteins with molecular
weight of 186 and 225 kDa, respectively, showed a single
sedimenting boundary (Figure 6C and 6D). The spread
observed for PKS12D1 was also investigated at different
protein concentrations, and a similar spreading pattern was
observed in the sedimentation velocity profiles. These studies
clearly suggested that PKS12 protein forms a large supra-
molecular assembly, probably through intermolecular inter-
actions mediated by N- and C-termini helices. PKS proteins
are known to posses weak intermolecular interactions, as has
been demonstrated for DEBS [32] and Pps proteins (O.A.
Trivedi and R. S. Gokhale, unpublished data) by using gel
filtration chromatography. The number of species observed
in the analytical ultracentrifugation studies could thus
correspond to different states of oligomerization. Similar
sedimenting profiles of intermolecular association has been
previously observed for histone proteins [33].
Since intermolecular interactions in PKS12 protein is
expected to be through the linker residues, we decided to
completely swap the Nter residues with an N-terminus region
from mycobacterial PpsA protein [20]. PpsA is the first
module of the DIM biosynthetic machinery and contains an
ACP loading domain at its N-terminus. This protein also does
not show any coiled-coil region at its N-terminus end. This
fusion construct of PKS12D1 showed extremely poor catalytic
activity, thus emphasizing the significant role of these linker
residues (Figure S3). We also performed analytical ultra-
centrifugation studies on this linker-change PKS12D1 (Figure
S4). Interestingly, the scatter in sedimenting boundaries
markedly observed for the wild-type protein was completely
abolished. We then decided to carry out product analysis
using radio-HPLC.
Analysis of the linker-change protein indicated that this
protein could carry out only one round of malonyl-CoA
condensation to synthesize C8 fatty acid (red trace in Figure
7). Clearly, this linker-change has abrogated the ability of
PKS12D1 to perform iterations through formation of higher
order oligomers. In order to directly explore the role of
PKS12 linker residues, we decided to make site-specific
Figure 4. Radio-HPLC and Mass Spectrometry Characterization of PKS12D1 Products
(A) Characterization of products on HPLC. The radioactive product synthesized by PKS12D1 was analyzed on reverse-phase HPLC, and the elution times
were determined by a radioactive detector. The reaction was primed with a hexanoyl starter that undergoes two carbon extensions with MCoA. The
product peaks superimpose with radioactive standards. The traces are stacked with an x-axis offset for clarity.
(B) Autoradiograph of the HPLC-resolved PKS12D1 products that were concentrated and analyzed by radio-TLC. The Rf of various bands is C8 (0.468), C10
(0.476), C12 (0.492), C14 (0.507), C16 (0.523), and C18 (0.539).
(C) ESI-MS analysis of the 29.46-min HPLC peak. Molecular ion peak of 199.17 confirms the eluent to be lauric acid. Isotopic distribution is in
concordance with radioactive substrates utilized in the assay.
(D) Tandem MS of [M-H]1199.17 peak. The fragmentation pattern was similar to standard lauric acid corresponding to decarboxylation (154.93) and loss
of water (181.17) from the parent ion.
(E) Tandem MS of the [M*-H]1 14C peak of lauric acid 201.17 peak. The characteristic peaks show mass difference of 2, corresponding to 14C radioisotope.
doi:10.1371/journal.pbio.0060163.g004
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mutants. Based on our PKS12 docking domain model (Figure
5C), we predicted a strong ionic interaction between E20
from N-terminus with C-terminus R4147 residue. The
PKS12D1 E20S mutant protein showed a 5-fold decrease in
its catalytic turnover. Quantitative radio-HPLC analysis also
showed greater than 5-fold decrease in its product formation
(blue trace in Figure 7). This compromised activity resulting
from a change in one amino acid in its linker provides strong
evidence of their requirement in efficient catalysis. H7D
mutation remarkably led to enhancement of catalytic activity
(black trace in Figure 7). Although the exact reason for this
behavior is not clear, our computational analysis suggests that
such a modification could provide favorable intrahelical
contacts. Moreover, sequence alignment in this region is
rather poor, and minor structural alterations can clearly
provide a stabilizing effect. A double mutant constructed by
combining these two mutations clearly showed an additive
effect (green trace in Figure 7). The product profile was
somewhat an average of two independent mutations. It is
interesting to note that products formed from higher
iterations were significantly lower in comparison to wild-
type and H7D proteins. Clearly, single amino acid substitu-
tions in the noncatalytic regions show effect on the catalytic
rates of product formation, thus reemphasizing their im-
portance in mycoketide biosynthesis through intermolecular
iterative catalysis.
Protein Concentration-Dependent Changes in PKS12D1
Product Profile
Since intermolecular interactions show dependence on
concentration, we examined the formation of products by
PKS12D1 at different protein concentrations. For an inter-
molecular iterative catalysis, the formation of the final
product would be dependent on the number of protein
molecules participating in the multimeric assembly. We
therefore hypothesized that formation of long-chain prod-
ucts would be facilitated at higher concentrations, whereas at
lower concentration, the product profile should support
biosynthesis of short-chain fatty acids. We investigated the
product profile using radio-HPLC at three different concen-
trations of 0.97 lM, 1.94 lM, and 3.88 lM by using hexanoyl-
NAC as the starter unit. As is evident from Figure 7B, the
maximum amount of product formed at the lowest concen-
tration corresponds to a single round of condensation of C2
unit. Moreover, all subsequent products are produced at
lower amounts than the C8 product. At the highest protein
concentration, there is favorable equilibrium towards for-
mation of higher order multimeric species, and as can be
observed from Figure 7B, there is a clear shift in product
profile pattern, and C8 is the lowest of all the products. Such
an effect would not be observed for proteins that would use
an intramolecular iterative mode of catalysis.
Specific Inhibition of Catalysis by C-Terminus Linker
Peptide
Since the supramolecular organization of PKS12 protein is
proposed to be through N- and Cters, we wanted to
investigate whether linker peptides would disrupt protein-
protein interactions and thus affect catalysis. We therefore
decided to assay PKS12D1 protein in presence of varying
concentrations of purified Cter peptide. Towards this end, we
cloned and expressed Cter peptide of PKS12 protein in BL-21
strain of E. coli by using T7 expression vector. Purification by
Ni2þ-NTA chromatography followed by anion exchange
chromatography yielded PKS12 Cter peptide at high purity.
Coincubation of this peptide with PKS12D1 protein showed a
clear decrease in the formation of enzymatic products (Figure
8A, lanes 1–5). This was further confirmed and quantitated by
radio-HPLC analysis of PKS12D1 reactions (Figure 8B), in
which a marked change in product profile was observed. As a
Figure 5. PKS12 Models and Identification of Interacting Residues
(A) The end-to-end orientation of PKS12 is shown. Module 1 of PKS12 is shown in cyan and module two in copper brown, except the KS and ACP
domains. The KS domains are shown in green and the ACP domains in yellow.
(B) The active site residues of KS and ACP domains are shown in ball and stick, and the distances are shown.
(C) Model for the docking domains of PKS12 generated by SCRWL and energy minimized using CVFF force field of Insight II. The interacting residues of
the N- and the Cters are shown.
doi:10.1371/journal.pbio.0060163.g005
PLoS Biology | www.plosbiology.org July 2008 | Volume 6 | Issue 7 | e1631590
Modularly Iterative Catalysis by PKS12
control, an equivalent concentration of bovine serum
albumin protein was also used in the assay, which showed
no effect on the enzymatic activity (Figure 8A, lane 7).
The specificity of inhibition by Cter peptide was further
investigated by using a covalently concatenated Cter–Nter
peptide of PKS12. Such a Cter-Nter fusion construct was
previously used for structural elucidation of docking domain
in erythromycin polyketide synthases, in which these linkers
form a stable docking complex by forming a pseudo four-
helix bundle [25]. The Cter-Nter peptide was expressed in E.
coli by splicing Nter at the end of the Cter sequence. The
propensity of Cter and Cter-Nter peptides to adopt helical
conformations was investigated by using circular dichroism
(CD). The ratio of the negative molar ellipticities at 220 and
208 nm is 0.65 for Cter peptide and 1.08 for Cter-Nter
peptide. Ratio of approximately 1.0 has been suggested to be
typical of interacting a-helices [34,35]. Taken together, these
CD studies suggest that Cter peptide forms a-helices, which
together with Nter peptide forms an interacting pseudo four-
helix bundle. Enzymatic assays performed in the presence of
Cter-Nter peptide showed no inhibition of PKS12D1 catalytic
function (Figure 8A, lane 6). These studies thus demonstrate
that Cter peptide specifically perturbs PKS12D1 oligomeriza-
tion by competitively interacting with the Nter region of
PKS12D1 protein.
Atomic Force Microscopy Analysis of PKS12D1
Multimeric organization of PKS12 protein was further
validated by performing atomic force microscopy studies.
PKS12D1 protein from the assay mixture was used for
visualization under noncontact acoustic AC mode. Figure
8C shows the presence of singular particles and some linear
oligomers randomly distributed over the entire surface.
Singular particle dimensions as analyzed by SPIP software
could correspond to native monomers of PKS12D1. Interest-
ingly, a distinctive pattern of linear multimeric species of
varying length could also be observed. Using the height
scaling method for these measurements, the linear multi-
meric species are not loosely interacting groups of single
particles, instead, are professedly to be unified entities. These
studies reinforce association between protein molecules.
Intermolecular Acyl Chain Transfer between Two Proteins
The unambiguous proof of intermolecular iterative mech-
anism of biosynthesis for mycoketide was established by
designing an assay in which direct transfer of acyl chain from
ACP of one protein molecule onto the KS domain of another
Figure 6. Sedimentation Velocity Analyses
Analysis of PKS12 (A), PKS12D1 (B), PKS13 (C), and PKS2 (D) by sedimentation velocity in the XL1-analytical ultracentrifuge in 50 mM phosphate buffer
(pH 7.2). The data were analyzed to yield the integral distribution of sedimentation coefficients.
doi:10.1371/journal.pbio.0060163.g006
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PKS protein molecule could be demonstrated. Towards this
end, we cloned and purified the ACP2 domain along with the
Cter (ACP2Cter) of PKS12. The ACP2Cter protein was
expressed in the apo-form and then Sfp protein was used to
directly load 14C-hexanoyl phosphopantetheine group onto
the catalytic Ser of ACP [36]. Coincubation of this protein
with PKS12D1 showed facile transfer of radioactivity to this
large PKS protein (Figure 9, lane 1). This transfer was not
observed for the KS active site mutant protein of PKS12D1
(C2226A) (Figure 9, lane 2). The specificity of the interactions
was further investigated by using another ACP protein
(Rv1344) from M. tuberculosis. Although the Rv1344 protein
could be acylated with 14C-hexanoyl phosphopantetheine
group, no transfer could be seen on incubation with PKS12D1
(Figure 9, lane 3). Appropriate control experiments showed
no direct labeling of PKS12D1, both in the presence or
absence of Sfp protein (Figure 9, lanes 4 and 5). Taken
together, these studies explicitly demonstrate specificity of
intermolecular interactions and also of transfer of acyl chain
from the phosphopantetheine group of ACP to the catalytic
Cys residue of the KS domain.
Discussion
This study unravels a novel biosynthetic mechanism by
which mycobacterial PKS12 protein is involved in the
biosynthesis of the acyl chain of MPMs. Cell-free reconstitu-
tion of a 431-kDa PKS12 protein along with systematic
biochemical analysis has facilitated characterization of a
unique supramolecular organization. We show that this
assembly is mediated through precise intermolecular inter-
actions between its N- and Cters in a head-to-tail association.
Figure 7. Quantitative Radio-HPLC Analyses of Linker-Change and Single Amino Acid Linker Mutants of PKS12D1 and Effect of Concentration on
PKS12D1 Catalysis
(A) The radioactive products synthesized by PKS12D1 and PKS12D1 mutant proteins were analyzed on reverse-phase HPLC, and the elution times were
determined by using a radioactive detector. All reactions were primed by hexanoyl starter that undergoes two carbon extension(s) with MCoA. Trace for
E20S mutant (blue) shows exact retention time while traces of all other mutant proteins are stacked with an x-axis offset for clarity; linker-change
protein (red), H7D þ E20S mutant (green), wild-type PKS12D1 (pink), and H7D mutant (black). Chain lengths of standard fatty acids eluting at these
retention times are marked on these stacked traces. Value of 0.01 V is considered as background, based on the control experiments.
(B) Comparison of concentration dependent changes in the product profiles catalyzed by PKS12D1. Gradation in color indicates increase of protein
concentration for each set of peaks, which in turn depict the product formed. At higher protein concentration, more of longer chain length products are
synthesized, since there is a shift in equilibrium towards higher order multimeric species.
doi:10.1371/journal.pbio.0060163.g007
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The organization of this supramolecular assembly could be
explained based on the recent three-dimensional structures
of FASs [23] and the high resolution structure of KS-AT
didomain from module 5 of erythromycin PKS [24]. The
overall X-shaped dimeric structure of FAS is built around KS
dimer interface. DH and ER domains also provide stability to
this homodimeric protein, whereas AT and KR catalytic
domains are located away from the dimer interface. It is clear
from these structures that the ACP domain undergoes large
conformational changes. The phosphopantetheine arm on
ACP is expected to reach out to various domains within the
same module and also to the KS domain of the next module
to facilitate catalysis in these modular proteins [26].
The noncovalently associated cognate modules have been
proposed to interact through C- and N-terminus helices that
form an independent docking complex [21,25]. As demon-
strated in the DEBS KS-AT structure, the N-terminus helix
protrudes away from the KS dimer interface and forms a
stable four-helix bundle with C-terminus helices of the
previous module. The two homodimeric modules thus are
arranged in an end-to-end fashion [26]. Since positions of
modules could be changed by suitable engineering of linkers,
the organization of two covalently linked contiguous modules
is expected to follow similar organization [2,21]. PKS12
protein, investigated in this study, possesses a bimodular
organization, which was proposed earlier to catalyze five
rounds of alternative condensations of methylmalonyl and
malonyl units through an iterative mechanism. Such a
biosynthetic route would require transfer of intermediate
chain from ACP of module 2 to KS of module 1. Based on
present understanding of modular assembly, this chain
transfer seems unfeasible. Therefore, in this study, we have
systematically dissected programming of PKS12 to biosynthe-
size mycoketide.
In recent years, ‘‘stuttering’’ as well as ‘‘skipping’’ of
modules has been reported during biosynthesis of polyketides
that deviate from the linear processive mechanistic logic of
modular biosynthesis [37–39]. The modular PKSs of borreli-
din and aureothin are two recent examples that illustrate a
controlled iterative utilization of selective modules during
polyketide biosynthesis [40,41]. We therefore first confirmed
the specificity of AT domains from two modules of PKS12 to
Figure 8. Effect of Cter Peptide on PKS12D1 Catalysis and AFM Analysis of PKS12D1
(A) Effect of Cter peptide, Cter-Nter concatenated peptide, and BSA on PKS12D1 catalysis. Specific inhibition of enzymatic activity by C-ter peptide can
be seen from lanes 1 to 5. C-terminus peptide competes with other PKS12D1 molecules and thus specifically inhibits product formation. BSA and the
concatenated C- and N-ter linker, which in itself forms a stable docking complex, does not interfere with PKS12D1 catalysis.
(B) Radio-HPLC analysis of PKS12D1 reaction inhibited by five times molar excess of Cter peptide. The solid curve indicates the control run without any
Cter peptide, and the dotted curve shows the profile for inhibited assay.
(C) AFM analysis of PKS12D1 showing multimeric organization.
doi:10.1371/journal.pbio.0060163.g008
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confirm that the two modules are used alternately during
mycoketide biosynthesis. This experimental confirmation is
in agreement with our previous studies, in which we had
demonstrated that a crucial Phe residue acts like a gatekeeper
that discriminates between malonate and methyl malonate
specificity [42]. The module 2 of PKS12 protein indeed
possesses this important Phe residue that restricts its
specificity to malonyl extender unit. The corresponding
amino acid in module 1 is Ser and therefore is able to utilize
methylmalonyl extender units.
In vitro enzymatic assays for PKS12 and PKS12D1
confirmed that this protein could indeed synthesize mycoke-
tide. Detailed analysis of the N-ter and C-ter sequences
suggested a modular mode of catalysis for PKS12. The
organization of PKS12 proteins to form a larger molecular
assembly was demonstrated by analytical ultracentrifugation.
The significance of this organization was investigated by
replacing N-ter and also by site-specific mutagenesis of
crucial amino acids. Although the linker-change protein led
to a single round of chain extension, the single amino acid
mutants showed appreciable change in overall catalysis.
Similar studies earlier with DEBS protein has shown crucial
role of single amino acids in forming a docking complex [43].
More evidence for intermolecular iterative catalysis was
provided by investigating the concentration-dependent
changes in the product profiles of PKS12D1. At higher
protein concentration, more of longer chain products are
synthesized, since there is a shift in equilibrium towards
higher order multimeric species. Furthermore, the Cter
showed specific inhibition of enzymatic activity by disrupting
protein–protein interactions while competing for the cog-
nate N-ter of PKS12 protein. Quite remarkably, the docking
domain consisting of Cter-Nter concatenated protein does
not inhibit catalysis. CD analysis of these linker peptides
supports the formation of docking domains through inter-
acting helices. The imaging studies of PKS12D1 performed by
using AFM also clearly showed propensity to form oligomeric
structures. An unambiguous proof of this novel organization
comes from our experiment in which we demonstrate specific
transfer of acyl chain from (n 1) protein to the next protein
(n), which are designed to specifically interact through C- and
Nters, respectively.
PKS12 protein thus forms a modular assembly to perform
repetitive condensation analogous to iterative proteins. We
therefore refer this mechanism of catalysis as ‘‘modularly
iterative’’ (Figure 10). To the best of our knowledge, this is
probably the first example wherein intermolecular iterative
catalysis has been characterized by forming a novel structural
organization. Interestingly, two recent studies have provided
evidence for the formation of a large, singular mega-complex
involving several PKS and FAS proteins [44,45].
Biosynthesis of MPMs would require other downstream
enzymes that would release and phosphorylate the nascent
acyl chain and then carry out final mannosylation. The
computational analysis of this region in the Mtb genome
suggests few putative enzymes that could be involved in the
complete biosynthesis of MPMs. Associated with this cluster is
LipT, possessing an esterase motif, which could release the
Figure 9. ACP to PKS Transfer Assays
Sfp from B. subtilis was used to label ACP2Cter of PKS12 (lane 1 and 2) and a noncognate ACP protein, Rv1344, from M. tuberculosis with 14C hexanoyl
CoA. Although ACP2Cter was able to transfer the label to PKS12D1 (lane 1), no transfer was seen when either the KS mutant of PKS12D1 was used (lane
2) or when a noncognate ACP with PKS12D1 was used (lane 3). Minus ACP control experiment did not show any label on PKS12 (lane 4); there was also
no direct labeling of PKS12D1 observed (lane 5)
doi:10.1371/journal.pbio.0060163.g009
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mycoketide from PKS12, similar to the lovD protein from
lovastatin biosynthesis [11]. Alternatively, Rv2047c could
reductively release alkyl chain from PKS12 protein. Rv2047c
protein shows homology with recently characterized reduc-
tive domains from multifunctional non-ribosomal peptide
synthetases. This protein also contains a swivel domain
commonly found in phosphoenol pyruvate (PEP)-utilizing
enzymes that may be required for phosphorylation. Located
upstream of PKS12 is Ppm1, encoding a polyprenol mono-
phosphomannose synthase that could mannosylate the
phophorylated alkyl chain [46].
The novel intermolecular iterative biosynthetic mechanism
identified in this study provides new perspective to our
understanding of polyketide biosynthetic machinery. This
study also highlights clever ways by which mycobacteria
utilize polyketide biosynthetic machinery to produce exotic
lipid metabolites.
Materials and Methods
The bacterial artificial chromosome (BAC) library of M. tuberculosis
H37Rv was obtained from the Pasteur Research Institute, France.
Radioactive malonyl CoA were purchased from Perkin Elmer Life
Sciences (1.9166 GBq/mmol) and radioactive methylmalonyl CoA was
purchased from American Radiolabeled Chemicals (55 mCi/mmol). E.
coli XL1-blue and E. coli BL21 (DE3) were used as cloning and
expression strains, respectively. All other chemicals used were of
analytical grade.
Cloning of pks12 and and pks12 constructs. BAC genomic DNA of
M. tuberculosis H37Rv [47] was digested with restriction enzyme NheI,
and the fragments were cloned in a NheI-digested vector, pTC1.
Cloning vector pTC1 has NdeI to HindIII multiple cloning site region
of pET28c inserted in the EcoRV site of pBluescript-SKþ (pBS)
vector. NheI site was specifically utilized to obtain a 14,412-bp
genomic DNA fragment, which includes the complete pks12 gene.
Gene pks12 was cloned in two parts from pTC2 which contains this
14,412-bp fragment. In brief, the N-terminus 827 bp of pks12 was
amplified (primers RSG675 to RSG678) by overlap extension PCR
while inactivating an NdeI (632 bp) site via silent mutations to
facilitate cloning. This NdeI (1 bp) to PstI (827 bp) fragment was
cloned in the SnaBI site of pLITMUS 28, and the construct was
further used to insert a PstI (827bp)–PstI (6,896 bp) fragment from
pTC2 to yield pTC5. The C-terminus 1,379-bp fragment was PCR
amplified using primers RSG679 and RSG681. The AscI (11,077 bp)–
HindIII (12,456 bp) fragment was cloned in pNEB193 followed by
insertion of NdeI (6,701 bp) to AscI (11,077 bp) fragment from pTC2.
This NdeI (6,701 bp) to HindIII (12,456 bp) fragment was inserted in
pET21c (þ) followed by insertion of NdeI (1 bp)–NdeI (6,701 bp) from
pTC5 to create PTC10, the expression plasmid for PKS12 with a C-
terminal polyhistidine tag. Primer sequences used for cloning are
given in Table S2.
pks12D1 was constructed by deleting BsaBI (112 bp)–BsaBI (6,178
bp) fragment from pTC5. The clone thus obtained was called pTC13.
pTC13 was utilized to insert the NdeI (1 bp) to NdeI (6,701 bp)
fragment containing this deletion alongside NdeI (6,701 bp) to
HindIII (12,456 bp) fragment in pET21c (þ). The clone obtained was
called pTC15 and was used for the purification of PKS12D1.
The linker-change mutant of pks12 was constructed by replacing
the N-terminal NdeI to BsaBI fragment of pks12 with the N-terminal
NdeI to BsaBI fragment of ppsA gene by using the conserved BsaBI
site present at the start of the KS domain. Although BsaBI site was
already present in pks12, it was engineered in ppsA via silent
mutations.
For construction of the PKS12 Cter peptide, the C-terminus 243
bp was PCR amplified (primers RSG1505, RSG1506) from pTC2 while
engineering restriction sites at the terminal ends to facilitate cloning.
For concatenated Cter-Nter fusion construct, Cter and Nter were
separately PCR amplified (primers RSG1426, RSG1427 for Cter and
RSG1428, RSG1430 for Nter) while engineering a PstI site at the end
of Cter and PstI site at the beginning of Nter to facilitate their
joining.
AT2 null mutant of PKS12 was constructed by insertion of NdeI (1
bp)–NdeI (6,701 bp) from pTC5 in NdeI-digested AT mutant of
PKS12D1, pTC23.
ACP2Cter was PCR amplified (primers RSG 1718, RSG 681) and
cloned in pET21c (þ) expression vector.
Site-directed mutagenesis. Site-directed mutagenesis was used to
generate the point mutants of pks12D1. The mutations are shown in
Table S1, and the mutagenic primers are shown in Table S2. To
minimize errors, small fragments containing the region of interest
Figure 10. Schematic Representation of Modularly Iterative Catalysis
Supramolecular organization of PKS12 protein formed by interactions between N- and Cters.
doi:10.1371/journal.pbio.0060163.g0010
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were subcloned and inserted back after mutations were introduced.
All mutants were constructed by using Quickchange Site Directed
Mutagenesis Kit (Stratagene). Mutations were confirmed by restric-
tion analysis and by DNA sequencing.
Expression and purification of proteins. All proteins were ex-
pressed and purified using the following procedure. The expression
plasmids were cotransformed in BL21-DE3 strain of E .coli with
pRSG56 to enable coexpression of Sfp for phosphopantetheinylation
of the ACP domain wherever required. The cells were grown at 30 8C
in LB medium with 50 lg ml1 of antibiotic (carbenicillin/kanamycin)
to an absorbance of 0.6 at 600 nm. The cells were incubated on ice for
10–15 min, and induced with 0.1 mM to 1 mM isopropyl thio–b-D-
galactoside for 12–18 h at an appropriate temperature (22 8C to 37
8C). The cells were harvested by centrifugation (3,500 g, 10 min;
Beckman Coulter Allegra 6R), resuspended in buffer A (50 mM Tris
chloride [pH 8.0] containing 10% glycerol) containing 150 mM NaCl,
lysed using a French press, and cellular debris was removed by
centrifugation (24,000 rpm, 40 min; Sorvall evolution RC, rotor: SA
300). Polyethylene imine was added to a final percentage of 0.1%, and
DNA pellet was removed by centrifugation (20,000 rpm, 20 min;
Sorvall evolution RC, rotor: SA 300). Ni2þ-nitrilotriacetic agarose
resin was added to the supernatant (0.75 ml l1 of culture), and the
proteins were purified using affinity chromatography with increasing
concentration of imidazole in buffer A. Anion exchange chromatog-
raphy was performed by using a 6-ml Resource-Q column and AKTA
chromatography system (Amersham). The protein was purified in
buffer B (100 mM phosphate buffer [pH 7.2] containing 10% glycerol)
and eluted with an increasing gradient of 1 M NaCl in buffer B with a
flow rate of 2 ml min1.
ACP2Cter expressed as inclusion bodies at all temperature and
IPTG concentrations tested. After French press, the pellet containing
inclusion bodies was resuspended in buffer containing 2 M Urea in
100 mM phosphate buffer (pH 7.2), 10 mM Tris buffer (pH 8.0) and 1
mM DTT. Supernatant was separated from the 2 M pellet by
centrifugation (15,000 rpm, 30 min), the pellet was resuspended in
a higher concentration of urea until the concentration reached 8 M,
and supernatant was separated at each stage. SDS-PAGE analysis of
all the fractions showed presence of ACP2Cter in 2 M fractions. This
suspension was subjected to a 100-fold ‘‘snap-dilution’’ in the
refolding buffer containing 50 mM Tris, 10% Glycerol and 150 mM
NaCl. The refolded protein was purified and used for transfer assays.
Protein concentrations were determined by using BCA protein
estimation kit (Pierce).
Labeling of enzymes by 14C-methylmalonyl- and 14C-malonyl-CoA.
Enzymes (1–5 lM) were incubated with 14C-MCoA and 14C-MMCoA
(36 lM) at 4 8C for 2 min. The reactions were quenched by addition of
SDS-PAGE loading dye lacking any reducing agents like dithiothreitol
or b-mercaptoethanol. Samples were directly loaded on a 6% SDS-
PAGE gel, and electrophoresis was performed at 25 mA until the dye
front ran out. The gel was dried and analyzed using a phosphor-
Imager (Fuji BAS5001).
Product formation assays. PKS12 enzymatic assays included 100
mM phosphate buffer (pH 7.2), 150 lM acyl-NACs, 75 lM MCoA, 75
lM MMCoA, 7.2 lM 14C-MCoA, 7.2 lM 14C-MMCoA, 4 mM NADPH,
10% glycerol, 2 mM Tris (2-carboxy ethyl) phosphine hydrochloride
(TCEP), and 2.5–4.5 lM protein in 100-ll reaction volume. The
reactions were incubated at 30 8C for 6–12 h. The products were
released with 45% KOH followed by acidification and extraction in
hexanes or ethyl acetate. The extract was spotted on TLC plate that
was developed by using 40:60:1 hexanes:ether:acetic acid. The radio-
TLC plates were analyzed by using a phosphorimager. For PKS12D1,
the enzymatic assays included all the components except MMCoA.
For radio-HPLC assays, the concentration of 14C-MCoA was
increased to 25 lM while keeping the total MCoA concentration as
100 lM. The band of interest was scraped from TLC, extracted in
ethyl acetate, concentrated and injected on C18 reverse-phase
column (gradient: 100% B in 20 min, 100% B in 40 min, 20% B in
60 min; A: H2O, B: 5% methanol in ACN with 0.1% formic acid) on
HPLC (Shimadzu). To analyze the HPLC eluted peaks, PKS12D1
products were first run on TLC plates, these were then extracted and
separated on HPLC and then further analyzed on TLC plates. The
radioactivity was monitored online by a radioactive detector (IN/US
system b-RAM Model 3). For kinetic analysis, radiolabeled products
were quantified using PhosphorImager (Fuji BAS5001).
For competition experiments, the competing proteins (Cter, Cter-
Nter, and BSA) were titrated into reaction mixtures containing 100
mM phosphate buffer (pH 7.2), 75 lM MCoA, 7.2 lM 14C-MCoA, 4
mM NADPH, 10% glycerol, 2 mM TCEP, and 2.5 lM protein in 100-ll
reaction volume. The reactions were analyzed in a manner similar to
PKS12D1 assays.
ACP to PKS transfer assays. The ACP to PKS transfer assays were
carried out in two steps wherein first the ACP protein was
exogenously labeled with 14C Hexanoyl CoA in a reaction containing
45 lM 14C Hexanoyl CoA, 12.5 mM MgCl2, and the Bacillus subtilis
enzyme Sfp [48]. The reaction was carried out for 15 min at 37 8C,
quenched with 0.05 M EDTA, and PKS proteins were added to a final
concentration of 1.5 to 2 lM. The reaction mixture was incubated for
15 min at 30 8C for the transfer to occur. The reactions were
quenched by addition of SDS-PAGE loading dye lacking any reducing
agents, such as dithiothreitol or b-mercaptoethanol. Samples were
directly loaded onto a 10% SDS-PAGE gel, and electrophoresis was
performed at 25 mA. The gel was dried and analyzed using a
Phosphorimager (Fuji BAS5001).
Synthesis of alkyl NAC thioesters. Various alkyl NAC thioesters
and 9-hydroxy decanoyl NAC was synthesized according to a
modified protocol reported earlier [20,49]
Sequence analysis and structural modeling. Primary sequence of
the gene was obtained from Tuberculist (http://genolist.pasteur.fr/
TubercuList/). Secondary structure analysis and multiple sequence
alignment for the PKS12 chimera model were carried out by using
seqweb software. Domain boundaries for PKS12 were obtained from
SEARCHPKS, a program developed for detection and analysis of PKS
domains (http://rd.plos.org/pbio.0060163). The chimera model for
linkers was built using SCRWL [29] in which the intervening loops of
the DEBS docking domains were kept and only the interacting helices
were changed to identify putative interacting residues. The model for
bimodular PKS12 was generated by docking KS-AT segment of
module 2 with DH-ER-KR segment of module1 using the software 3D-
DOCK [50]
Sedimentation velocity analysis. Sedimentation velocity experi-
ments were conducted with an optima XLI instrument (Beckman
Coulter) using an An 60Ti four-hole rotor at 35,000 rpm at 20 8C with
three 420-ll samples in standard double-sector Epon centerpieces
equipped with quartz windows. The sample A280 ranged from 0.6–0.9.
Sedimentation velocity data were collected using continuous scan
mode set at 0.001-cm radial increments. The scans were analyzed by
the method of Van Holde-Weischet [51]. These data yielded the
integral distribution of sedimentation coefficients plotted as the
boundary fraction versus S20,w (sedimentation coefficient corrected
for water at 20 8C )
Atomic force microscopy. Pico plus atomic force microscope
(Agilent Technologies) was used in acoustic AC (noncontact) mode
for imaging. Images were recorded in air with either a bare mica
surface or mica with the samples (normal spring constant of
cantilever: 2.8 N/m, frequency: 59.722 kHz). The PKS12D1 reaction
mixture was diluted 20-fold with 100 mM phosphate buffer and was
immobilized on freshly cleaved mica for 30 s. The sample was washed
with nanopure water, dried under N2, and subjected to AFM analysis.
Circular dichroism analysis. CD spectra were recorded on a Jasco-
710 instrument equipped with a temperature cell holder. The spectra
were an average of ten scans, and the data were presented as mean
residual ellipticity (MRE) expressed in deg cm2 dmol1. The protein
concentrations were determined by using BCA protein estimation kit
(Pierce).
Supporting Information
Figure S1. PKS12 Activity in Absence of Any of the Two Extenders
PKS12 protein was assayed for activity as given in Materials and
Methods. While PKS12 was active in presence of both extenders (lane
1), absence of MCoA (lane 3), or MMCoA (lane 2) from the assays
rendered the protein inactive.
Found at doi:10.1371/journal.pbio.0060163.sg001 (70 KB PDF).
Figure S2. Effect of KS Inhibitor, Cerulenin, and Heat Inactivation
on Enzymatic Assays of PKS12
PKS12 protein (lane 1), PKS12 protein with 100 lM cerulenin (lane 2),
and PKS12 protein with ethanol equivalent to the volume of
cerulenin added (lane 3) were incubated at 30 8C for 1 h prior to
setting up assays as given in Materials and Methods. Extractions were
done in hexanes to extract only the polyketide product. Cerulenin
renders the KS domain inactive by forming a covalent adduct and
inhibits the reaction (lane 2). Preincubation (lane 1) and ethanol (lane
3) do not lead to any inhibition. PKS12 protein activity was further
confirmed by denaturing the protein by boiling at 100 8C for 10 min
and setting up assays (lane 4).
Found at doi:10.1371/journal.pbio.0060163.sg002 (63 KB PDF).
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Figure S3. PKS12D1, KS Mutant, AT Mutant, and Linker-Change
Protein Activity Assays
PKS12D1, KS mutant (C2226A), AT mutant (S2672A), and linker-
change protein were assayed for activity as given in Materials and
Methods. Although PKS12D1 showed robust activity (lane 1), KS
mutant (lane 3) and AT mutant (lane 4) are totally inactive. Lane 5
shows the activity assays for the linker-change protein, and no
background activity is seen in the absence of protein (lane 2).
Found at doi:10.1371/journal.pbio.0060163.sg003 (69 KB PDF).
Figure S4. Analytical Ultracentrifugation Analysis of Linker-Change
Mutant
Analysis of linker-change mutant of PKS12D1 by sedimentation
velocity in the XL1-analytical ultracentrifuge in 50 mM phosphate
buffer (pH 7.2). The data were analyzed to yield the integral
distribution of sedimentation coefficients.
Found at doi:10.1371/journal.pbio.0060163.sg004 (13 KB PDF).
Table S1. Highlighting Mutations for Site-Directed Mutagenesis of
Key Residues
Mutations are indicated in bold
Found at doi:10.1371/journal.pbio.0060163.st001 (11 KB PDF).
Table S2. List of Primers Used
Found at doi:10.1371/journal.pbio.0060163.st002 (8 KB PDF).
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